Top

Lung

Published in:

01-08-2018 | PULMONARY ASPIRATION

Gastro-Oesophageal Reflux and Aspiration: Does Laparoscopic Fundoplication Significantly Decrease Pulmonary Aspiration?

Authors: Oleksandr Khoma, Susanna Elizabeth Falk, Leticia Burton, Hans Van der Wall, Gregory Leighton Falk

Published in: Lung | Issue 4/2018

Abstract

Purpose

Pulmonary aspiration of gastric refluxate is one of the indications for anti-reflux surgery. Effectiveness of surgery in preventing pulmonary aspiration post-operatively has not been previously tested. The aim of this project is to assess effectiveness of anti-reflux surgery on preventing pulmonary aspiration of gastric refluxate.

Methods

Retrospective analysis of prospectively populated database of patients with confirmed aspiration of gastric refluxate on scintigraphy. Patients that have undergone anti-reflux surgery between 01/01/2014 and 31/12/2015 and had scintigraphy post-operatively were included. Objective data such as resolution of aspiration, degree of proximal aero-digestive contamination, surgical complications and oesophageal dysmotility as well as patient quality of life data were analysed.

Results

Inclusion criteria were satisfied by 39 patients (11 male and 28 female). Pulmonary aspiration was prevented in 24 out of 39 patients (61.5%) post-operatively. Significant reduction of isotope contamination of upper oesophagus supine and upright (p = 0.002) and pharynx supine and upright (p = 0.027) was confirmed on scintigraphy post-operatively. Severe oesophageal dysmotility was strongly associated with continued aspiration post-operatively OR 15.3 (95% CI 2.459–95.194; p = 0.02). Majority (24/31, 77%) of patients were satisfied or very satisfied with surgery, whilst 7/31 (23%) were dissatisfied. Pre-operative GIQLI scores were low (mean 89.77, SD 20.5), modest improvements at 6 months (mean 98.4, SD 21.97) and deterioration at 12 months (mean 88.41, SD 28.07) were not significant (p = 0.07).

Conclusion

Surgery is partially effective in reversing pulmonary aspiration of gastric refluxate on short-term follow-up. Severe oesophageal dysmotility is a predictor of inferior control of aspiration with surgery.

Barry DW, Vaezi MF (2010) Laryngopharyngeal reflux: more questions than answers. Clevel Clin J Med 77(5):327–334. https://doi.org/10.3949/ccjm.77a.09121 CrossRef

Falk GL, Beattie J, Ing A, Falk SE, Magee M, Burton L, Van der Wall H (2015) Scintigraphy in laryngopharyngeal and gastroesophageal reflux disease: a definitive diagnostic test? World J Gastroenterol 21(12):3619–3627. https://doi.org/10.3748/wjg.v21.i12.3619 CrossRefPubMedPubMedCentral

Postma GN, Halum SL (2006) Laryngeal and pharyngeal complications of gastroesophageal reflux disease. GI Motil Online. https://doi.org/10.1038/gimo46 CrossRef

Koufman JA, Aviv JE, Casiano RR, Shaw GY (2002) Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngology 127(1):32–35CrossRef

Blondeau K, Mertens V, Vanaudenaerde BA, Verleden GM, Van Raemdonck DE, Sifrim D, Dupont LJ (2008) Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 31(4):707–713. https://doi.org/10.1183/09031936.00064807 CrossRefPubMed

Lee JS, Collard HR, Raghu G, Sweet MP, Hays SR, Campos GM, Golden JA, King TE (2010) Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med 123(4):304–311. https://doi.org/10.1016/j.amjmed.2009.07.033 CrossRefPubMedPubMedCentral

Vaezi MF (2009) Extraesophageal Reflux. Plural Publishing, San Diego

Luketich JD (2014) Master techniques in surgery: esophageal surgery. Wolters Kluwer Health, Philadelphia

Martinucci I, de Bortoli N, Savarino E, Nacci A, Romeo SO, Bellini M, Savarino V, Fattori B, Marchi S (2013) Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis 4(6):287–301. https://doi.org/10.1177/2040622313503485 CrossRef

10.

Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H (1995) Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 82(2):216–222CrossRefPubMed

11.

Belafsky PC, Postma GN, Koufman JA (2001) The validity and reliability of the reflux finding score (RFS). Laryngoscope 111(8):1313–1317. https://doi.org/10.1097/00005537-200108000-00001 CrossRefPubMed

12.

Gibson SC, Wong SK, Dixon AC, Falk GL (2013) Laparoscopic repair of giant hiatus hernia: prosthesis is not required for successful outcome. Surg Endosc 27(2):618–623. https://doi.org/10.1007/s00464-012-2501-3 CrossRefPubMed

13.

Falk M, Van der Wall H, Falk GL (2015) Differences between scintigraphic reflux studies in gastrointestinal reflux disease and laryngopharyngeal reflux disease and correlation with symptoms. Nucl Med Commun 36(6):625–630. https://doi.org/10.1097/mnm.0000000000000289 CrossRefPubMed

14.

Kahrilas PJ, Dodds WJ, Hogan WJ, Kern M, Arndorfer RC, Reece A (1986) Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 91(4):897–904CrossRefPubMed

15.

Khoma O, Burton L, VanderWall H, Falk M, Falk GL (2017) Pathophysiology of laryngopharyngeal reflux disease: association with pulmonary aspiration on scintigraphy and abnormal oesophageal motility disease (under review)

16.

McShane PJ, Naureckas ET, Tino G, Strek ME (2013) Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 188(6):647–656. https://doi.org/10.1164/rccm.201303-0411CI CrossRefPubMed

17.

Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R (2006) The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101(8):1900–1920. https://doi.org/10.1111/j.1572-0241.2006.00630.x (quiz 1943)CrossRefPubMed

18.

Catania RA, Kavic SM, Roth JS, Lee TH, Meyer T, Fantry GT, Castellanos PF, Park A (2007) Laparoscopic Nissen fundoplication effectively relieves symptoms in patients with laryngopharyngeal reflux. J Gastrointest Surg 11(12):1579–1587. https://doi.org/10.1007/s11605-007-0318-5 (discussion 1587–1578)CrossRefPubMed

19.

Garg SK, Gurusamy KS (2015) Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003243.pub3 PubMedCrossRef

20.

Pearson JP, Parikh S, Orlando RC, Johnston N, Allen J, Tinling SP, Johnston N, Belafsky P, Arevalo LF, Sharma N, Castell DO, Fox M, Harding SM, Morice AH, Watson MG, Shields MD, Bateman N, McCallion WA, van Wijk MP, Wenzl TG, Karkos PD, Belafsky PC (2011) Review article: reflux and its consequences–the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21–23 April 2010. Aliment Pharmacol Ther 33(Suppl 1):1–71. https://doi.org/10.1111/j.1365-2036.2011.04581.x PubMedCrossRef

21.

Ludemann JP, Manoukian J, Shaw K, Bernard C, Davis M, al-Jubab A (1998) Effects of simulated gastroesophageal reflux on the untraumatized rabbit larynx. J Otolaryngol 27(3):127–131PubMed

22.

Giuliano C, Wilhelm SM, Kale-Pradhan PB (2012) Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis. Expert Rev Clin Pharmacol 5(3):337–344. https://doi.org/10.1586/ecp.12.20 CrossRefPubMed

23.

Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z (2017) Risk of death among users of proton pump inhibitors: a longitudinal observational cohort study of United States veterans. BMJ Open. https://doi.org/10.1136/bmjopen-2016-015735 CrossRefPubMedPubMedCentral

24.

Jobe BA, Richter JE, Hoppo T, Peters JH, Bell R, Dengler WC, DeVault K, Fass R, Gyawali CP, Kahrilas PJ, Lacy BE, Pandolfino JE, Patti MG, Swanstrom LL, Kurian AA, Vela MF, Vaezi M, DeMeester TR (2013) Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg 217(4):586–597. https://doi.org/10.1016/j.jamcollsurg.2013.05.023 CrossRefPubMed

25.

Ravi K, Katzka DA (2016) Esophageal Impedance Monitoring: Clinical Pearls and Pitfalls. Am J Gastroenterol 111(9):1245–1256. https://doi.org/10.1038/ajg.2016.256 CrossRefPubMed

26.

Cowgill SM, Gillman R, Kraemer E, Al-Saadi S, Villadolid D, Rosemurgy A (2007) Ten-year follow up after laparoscopic Nissen fundoplication for gastroesophageal reflux disease. Am Surg 73(8):748–752 (discussion 752–743)PubMed

27.

Fumagalli U, Bona S, Battafarano F, Zago M, Barbera R, Rosati R (2008) Persistent dysphagia after laparoscopic fundoplication for gastro-esophageal reflux disease. Dis Esophagus 21(3):257–261. https://doi.org/10.1111/j.1442-2050.2007.00773.x CrossRefPubMed

28.

Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 58(4):339–343CrossRefPubMedPubMedCentral

Title: Gastro-Oesophageal Reflux and Aspiration: Does Laparoscopic Fundoplication Significantly Decrease Pulmonary Aspiration?
Authors: Oleksandr Khoma
Susanna Elizabeth Falk
Leticia Burton
Hans Van der Wall
Gregory Leighton Falk
Publication date: 01-08-2018
Publisher: Springer US
Published in: Lung / Issue 4/2018
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-018-0128-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2018

The Role of ADAR1 and ADAR2 in the Regulation of miRNA-21 in Idiopathic Pulmonary Fibrosis

In Defense of Lady Windermere Syndrome

Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease

Ability of Exhaled Nitric Oxide to Discriminate for Airflow Obstruction Among Frequent Exacerbators of Clinically Diagnosed Asthma

SERPINA1 Hepatocyte-Specific Promoter Polymorphism Associate with Chronic Obstructive Pulmonary Disease in a Study of Kashmiri Ancestry Individuals

Circulating Survivin Levels in Obstructive Sleep Apnoea

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials